Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VI versus VIT for relapsed or refractory rhabdomyosarcoma
NL-OMON47843Phase 2Recruiting
- Sponsor
- Centre Oscar Lambret
- Start
- Oct 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of vincristine, irinotecan and temozolomide, sponsored by Centre Oscar Lambret. Started Oct 2012; status: recruiting.
02
Drugs
vincristineirinotecantemozolomide
Beyond the preview
Go deeper on NL-OMON47843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47843.